PlainRecalls

King Legacy, a wholly owned subsidiary of Pfizer

Compiled from official public sources by the publisher.

11 recalls on record · Latest: May 29, 2013

Subscribe to new King Legacy, a wholly owned… recalls (RSS)

Agency notice ledger

Federal filing book King Legacy, a wholly owned… LIGHT-BOOK · SINGLE-AGENCY

#1,360 of 14,151 · 11 notices · 0.011% archive

  • BOOK 11 notices
  • RANK #1,360 of 14,151
  • SHARE 0.011% archive
  • AGENCY FDA Drug (11)
  • CAT drugs
  • CATS 1 category
  • LATEST May 29, 2013
  • PHOTO Agfa Corp.

Nearest notice-volume peer: Agfa Corp. (0 notice gap)

King Legacy, a wholly owned subsidiary of Pfizer accounts for about 0.011% of the 104,423-notice archive on 11 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How King Legacy, a wholly owned… compares to 14,151 recalling firms

King Legacy, a wholly owned subsidiary of Pfizer ranks 1,360th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

King Legacy, a wholly owned… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

11 1360th of 14151 higher than 12,735 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-16

King Legacy, a wholly owned… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows King Legacy, a wholly owned subsidiary of Pfizer holds about 0.011% of archive notices alongside 11 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60793-857-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
FDA Drug Moderate May 29, 2013

Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

King Legacy, a wholly owned… holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (11 here — thin-book).

Agfa Corp. 11 Ajinomoto Foods North America Inc. 11 Akron Pharma, Inc. 11 Amendia, Inc 11 Aniara Diagnostica LLC 11

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Akron Pharma, Inc. 11 Arg Laboratories, Inc. 11 Bell Pharmaceuticals, Inc 11 Cipla 11

Frequently Asked Questions

How many federal recall notices name King Legacy, a wholly owned…? ▼
PlainRecalls indexes 11 distinct federal recall events naming King Legacy, a wholly owned subsidiary of Pfizer, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does King Legacy, a wholly owned… sit among other recalling firms? ▼
King Legacy, a wholly owned subsidiary of Pfizer ranks #1,360 of 14,151 by distinct recall-event count among 14,151 firms in this archive (90th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of King Legacy, a wholly owned…'s notices? ▼
FDA Drug accounts for 11 of this firm's 11 indexed notices.
What product category dominates King Legacy, a wholly owned…'s filing book? ▼
Filings for King Legacy, a wholly owned subsidiary of Pfizer span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
King Legacy, a wholly owned subsidiary of Pfizer: 11 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming King Legacy, a wholly owned subsidiary of Pfizer; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026